Document:

<PAGE>

                                  Exhibit 10(a)

                             CANCELLATION AGREEMENT

     THIS AGREEMENT is made and entered into as of November 1, 2002 by and among
Parker-Hannifin Corporation (the "Company"), Michael J. Hiemstra (the
"Executive") and the Irrevocable Trust Creating Vested Trusts for Children of M.
J. Hiemstra dated August 16, 1999 (the "Trust").

                                    RECITALS

     A.   The Company and the Executive are parties to an Exchange Agreement
dated as of October 29, 1999 (the "Exchange Agreement") whereby the Executive
agreed to the surrender of a portion of his future base pay in exchange for the
Company's agreement to be bound by the terms of an Executive Estate Protection
Plan Document (as defined in the Exchange Agreement).

     B.   The Company, the Executive and the Trust are parties to an Executive
Estate Protection Agreement dated as of October 29, 1999 (the "EEP Agreement")
whereby the Company has agreed to provide life insurance for the benefit of the
Executive and his wife by funding the premiums on a Policy (as defined in the
EEP Agreement) to be owned by the Trust.

     C.   Subsequent to the execution of the Exchange Agreement and the EEP
Agreement:

          (1)  the Internal Revenue Service has proposed regulations (the "Tax
Regulations") which may negatively affect both the Executive and the Company
from a financial standpoint; and

          (2)  Congress has enacted the Sarbanes-Oxley Act of 2002 (together
with the Tax Regulations, the "Recent Developments").

     D.   As a result of the Recent Developments, the Executive has requested
that the Company and the Trust agree to the cancellation of their respective
obligations under the Exchange Agreement and EEP Agreement.

<PAGE>

     E. The Company and the Trust are willing to accommodate the Executive's
request to cancel their respective obligations under the Exchange Agreement and
the EEP Agreement pursuant to the terms and conditions stated herein.

                                    AGREEMENT

     1. The Executive, the Company and the Trust agree that the Exchange
Agreement and the EEP Agreement shall be cancelled effective November 1, 2002
(the "Effective Date") and, except as specifically provided herein, no party
shall have any further obligation thereunder. For the avoidance of doubt, as of
the Effective Date, (a) Monthly Surrenders (as defined in the Exchange
Agreement) shall no longer be deducted from the Executive's future base pay from
the Company; and (b) the Company shall have no further obligation to pay
premiums for the Policy, including without limitation the premium payment due on
the Effective Date.

     2. As of the Effective Date, the Trust and the Company shall instruct the
Insurer (as defined in the EEP Agreement) in writing that they wish to surrender
the Policy for its cash value (the "Cash Value"), payable to the Company as
repayment for the funds provided by the Company for the acquisition and
maintenance of the Policy. The Cash Value shall belong to the Company.

     3. As of the Effective Date, the Company shall credit the Executive's
account in the Company's Executive Deferral Plan (the "EDP Account") with an
amount equal to 28.6% of the Cash Value (the "EDP Credit"). The EDP Credit shall
be allocated to the EDP Account in the same manner as the Executive's current
investment elections for the EDP Account.

     4. The provisions contained in Section 4 of the Exchange Agreement which
obligate the Company to disregard the Surrendered Compensation for purposes of
determining the Executive's benefits under the Company's Supplemental Executive
Retirement Program shall survive the cancellation of the Exchange Agreement.

     5. This Agreement shall be governed by and construed under the laws of the
State of Ohio.

                                       2

<PAGE>

     IN WITNESS WHEREOF, the Company, the Executive and the Trust have executed
this Agreement as of the date first above written.

                                   PARKER-HANNIFIN CORPORATION

                                   By:  /s/Thomas A. Piraino, Jr.

                                   Title: Vice President

                                   /s/Michael J. Hiemstra
                                   ----------------------------------
                                       Michael J. Hiemstra

                                   IRREVOCABLE TRUST
                                   CREATING VESTED TRUSTS FOR CHILDREN
                                   OF M. J. HIEMSTRA DATED August 16, 1999

                                   By: /s/David J. Hiemstra
                                       ------------------------------
                                           David J. Hiemstra
                                           Trustee

                                       3Distribution and Usage MOU

 
Exhibit 10.124

 
DISTRIBUTION AND USAGE MEMORANDUM OF
UNDERSTANDING 
 
This Memorandum of Understanding (the
“MOU”) is entered into by and between Safe Blood for Africa Foundation, a Delaware corporation (“SBFA”) and Calypte Biomedical Corporation, a Delaware corporation (“CBC”), and is made effective on December 10, 2002.

 
WHEREAS SBFA operates and/or assists governmental and
non-governmental organizations involved in the collection, testing, and processing of human blood and blood component donations in sub-Saharan Africa, and 
 
WHEREAS SFBA believes that pre-screening prospective blood donors with Calypte’s urine-based HIV antibody products may provide financial or logistic
benefits to these organizations, 
 
The parties hereby agree,
through the execution of this MOU to establish a formal distribution and usage agreement (“Agreement”) with essentially the same terms and conditions as described herein not more than three months following the date upon which this MOU is
executed. 
 
Definitions 
 
“Product” and “Products” shall mean one or more of the CBC
in vitro diagnostic test kits listed in Appendix A 
 
“Territory” shall mean, subject to further definition and conditions in this Agreement, all public or private entities whose sole or primary activity is related to the collection and processing of human blood donations in
sub-Saharan Africa. 
 
1. Proposed Appointment 
 
CBC proposes to appoint SBFA as its exclusive distributor of the Products in
the Territory, with the exception of the HIV-1 Serum Western Blot, for which SBFA would be appointed as a non-exclusive distributor in the Territory. 
 
2. Term 
 
This MOU shall be in effect for a period of three months from its date of execution. The proposed Agreement shall continue for a term of ten (10) years unless earlier terminated according to the
provisions of the Agreement, and as described herein. 
 
3.
Obligations of SBFA 
 
SBFA shall at all times describe CBC and
its Products in an accurate manner. 
 
SBFA shall provide to CBC
complete details on any institution that uses CBC products including the names, addresses, telephone, fax, or email information of key personnel. 
 

1 

 
SBFA shall also provide to CBC
such additional information as it may have and which may be relevant to the sale of Product, including but not limited to projected test volumes, the use of / price of competing products used, and reliability of funding. 
 
SBFA shall at all times respect its limitations on Territory. 
 
SBFA shall at all times conduct its business in compliance with local and
international laws and regulations. 
 
SBFA shall conduct all
training of laboratory personnel at its client institutions, and shall provide routine technical support to same. 
 
SBFA shall provide to CBC routine reports regarding Product performance complaints, as well as immediate notification of any Product performance issue
that either requires CBC technical involvement or potential recall. In the event that SBFA redistributes CBC Products, SBFA shall maintain lot number records to facilitate a recall should one ever be required, and shall provide all reasonable
assistance in such effort. 
 
SBFA shall directly, or through its
client institutions, assist CBC in acquiring such local regulatory approvals as may be required for the use of the Products at no cost to CBC. 
 
SBFA shall make best efforts to assist CBC, as CBC may request from time to time, in acquiring certain types of urine and/or serum samples. The provision
and delivery of such urine and/or serum samples shall be at CBC’s cost. Specifically, SBFA shall endeavor to acquire and provide to CBC at least fifty (50) matched serum and urine samples from individuals known to be infected with HIV-2, but
not HIV-1. 
 
4. Obligations of CBC 
 
CBC shall make commercially reasonable efforts to accept orders from, and ship
Product to SBFA or its client institutions whose orders comply with CBC’s then-current prices, terms, and conditions which may change from time to time at CBC’s sole discretion. Current policies regarding pricing, payment, shipping,
returns, and other allowances are described in Appendix B. 
 
CBC
shall make best efforts to ship Product to SBFA or its client institutions whose orders have been accepted by CBC in writing, subject to CBC’s sole discretion in the allocation of its inventory. 
 
CBC shall make reasonable commercial efforts to acquire local regulatory
approvals as may be required for use of the Products, but shall not be obliged to do so if in CBC’s sole opinion the costs and efforts required to make the Products legally marketable in a customer’s country are prohibitive. CBC shall
reimburse SBFA for government fees directly associated with such approvals and provide such Product as may be required for local clinical trials. 
 

2 

 
CBC shall train SBFA technical
representatives up to once per year at CBC’s facilities at CBC’s own expense, excepting travel and lodging expenses for the SBFA representatives. 
 
CBC shall be responsible for manufacturing and shipping the Product(s) and for the billing and collection of monies related thereto. 
 
For market introduction purposes CBC shall provide to SBFA on a schedule to be
determined on or before January 31, 2003 and at no charge to SBFA other than shipping, 125,000 tests of the Calypte HIV-1 Urine EIA (261 kits of Cat. No. 700000). CBC and SBFA understand and agree that notwithstanding the foregoing, CBC shall
provide to SBFA no less than 25,000 test kits in the first quarter of 2003 
 
5. Additional Territories and Products 
 
CBC shall negotiate distribution and usage rights for additional territories and for new products upon SBFA’s request, with the provision however that pre-existing agreements with third parties may make CBC contractually unable
to grant to SBFA such requested rights. In the absence of said pre-existing agreements, it is the intent of the parties to expand the territories and products governed by the proposed Agreement under the same terms as described herein, wherever
commercially desirable. 
 
6. CBC commercial policies

 
CBC agrees to fully inform SBFA of its commercial policies
concerning pricing, returns, allowances and other relevant activities upon request. 
 
7. Product Ownership 
 
CBC
warrants that it is the sole owner of the Products, and is free to enter into this MOU and the proposed Agreement, subject to limitations imposed by pre-existing distribution agreements within the Territory. 
 
8. Termination 
 
CBC, at its sole option, may immediately terminate this MOU or the proposed
Agreement with respect to the Territory, upon giving written notice to SBFA to this effect, whenever any of the following events occurs: 
 
(i) if SBFA at any time discontinues or abolishes its business, files a petition of bankruptcy or insolvency or admits in writing its
inability to pay its debts as they become due and payable, or if SBFA is adjudicated bankrupt or insolvent, or if there is filed any petition seeking reorganization of SBFA, or if a receiver is appointed for all or substantially all of SBFA’s
property, or if SBFA makes an assignment for the benefit of creditors or if any proceedings are instituted for the liquidation, or winding up of SBFA; 
 
(ii) if SBFA uses CBC’s trademarks or trade names or styles in any way which in CBC’s sole judgment might deceive or mislead the
consumer or which might in 
 
 

3 

 
any way damage
or impair the reputation or value of such trademarks, trade names, or styles; 
 
(iii) if SBFA fails to comply with any of the terms or conditions herein contained and, after notice by CBC requiring SBFA to make good such default, SBFA fails to cure such default within thirty (30)
days after receipt of such notice; 
 
(iv) if SBFA’s authority to carry on business is cancelled by competent authorities; 
 
(v) if control of SBFA should be transferred to another party, whether such party is a competitor of CBC or otherwise; or

 
(vi) all Products are deleted
from Appendix A. 
 
SBFA, at its sole option, may
immediately terminate this MOU or the proposed Agreement with respect to the Territory, upon giving written notice to CBC to this effect, whenever any of the following events occurs: 
 
(i) if CBC at any time discontinues or abolishes its business, files a petition of bankruptcy or insolvency
or admits in writing its inability to pay its debts as they become due and payable, or if CBC is adjudicated bankrupt or insolvent, or if there is filed any petition seeking reorganization of CBC, or if a receiver is appointed for all or
substantially all of CBC’s property, or if CBC makes an assignment for the benefit of creditors or if any proceedings are instituted for the liquidation, acquisition, or winding up of CBC; or 
 
(ii) if CBC fails to comply with any of the terms or
conditions herein contained and, after notice by SBFA requiring CBC to make good such default, Calypte fails to cure such default within thirty (30) days after receipt of such notice. 
 
(iii) if CBC’s authority to carry on business is cancelled by competent authorities;

 
9. Indemnification 
 
Each party agrees to defend the other party, and to hold the other party, its
owners, directors, employees, consultants, and representatives harmless from claims, judgments, settlements, awards, or fines levied against that party which are related to the Products, excluding those that may result from a breach of the proposed
Agreement or negligence or willful misconduct by the other party. This provision shall survive the term of this MOU and the proposed Agreement by five years. 
 
10. Relationship 
 
Nothing contained herein shall be construed as evidence that SBFA and CBC are partners or joint venturers. Nothing in this MOU or the proposed Agreement
is intended or shall 
 

4 

 
be construed to make SBFA an
agent or employee of CBC. The parties acknowledge and agree that SBFA does not have, nor shall SBFA hold itself out as having, any right, power, authority to create any contract or obligation, either express or implied, on behalf of, in the name of,
or binding upon CBC, or pledge CBC’s credit, or to extend credit in CBC’s name unless CBC shall consent thereto in advance in writing. 
 
11. Delegation 
 
Neither party shall have the right to delegate any of its obligations or duties under the proposed Agreement to a third party without the prior written
consent of the other party. 
 
12. Governing Law

 
This MOU and the proposed Agreement shall be deemed to have
been entered into in San Francisco, California and all questions concerning the validity, interpretation, or performance of its terms or provisions or of any rights or obligations of the parties hereto shall be governed by and resolved in accordance
with the laws of the State of California. 
 
13. Entire
Agreement 
 
This MOU constitutes a non-binding intent of the
parties to enter a formal Agreement between CBC and SBFA. 
 
14.
Non-disclosure 
 
SBFA acknowledges that CBC has the sole and
exclusive rights to the registered trademarks and proprietary information and technology associated with the Products. All information received by SBFA concerning the design, manufacture, ingredients, developments, sales, costs, and distribution pf
CBC’s Products constitutes a trade secret and shall not be used or otherwise disclosed by SBFA to any third persons without the prior written consent of CBC. This provision shall survive the term of this MOU and the proposed Agreement by a
period of five years. 
 
IN WITNESS WHEREOF, the parties have
executed this Memorandum 
 

	  CALYPTE BIOMEDICAL CORPORATION
	  	  	  	  SAFE BLOOD FOR AFRICA FOUNDATION

	
	  /s/ Nancy E. Katz        

	  	  	  	  /s/ Jeffrey M. Busch      

	  Nancy E. Katz
  President and CEO
	  	  	  	  Jeffrey M. Busch
  Chairman

	   
  Date:    12/10/02    

	  	  	  	  Date:    12/10/02    

 
 
 

5 

 
Appendix A – PRODUCTS

 

	  Cat. No. 700000
	   	  480 tests, HIV-1 Urine EIA (USFDA-approved)

	  Cat. No. 700000FC
	   	  as above, modified conjugate, not USFDA-approved

	  Cat. No. 98078
	   	  27 tests, HIV-1 Urine Western Blot (USFDA-approved)

	  Cat. No. 98002
	   	  27 tests, HIV-1 Serum Western Blot (USFDA-approved)

 
Appendix B –
CURRENT COMMERCIAL POLICIES 
 
CBC quotes prices FOB its
warehouses, net of all transportation, insurance, duties, taxies or other levies. CBC manufactures Western Blot kits in Rockville MD and EIA kits in Alameda, CA. 
 
Payment is required in advance by wire transfer, LC or similar method, in $US 
 
Products require 60 – 90 days to manufacture. Unforecasted orders will be
accepted and filled at CBC’s discretion 
 
Calypte reserves
the right to change its prices at its sole discretion, upon not less than sixty- (60) days advance written notice. Calypte shall endeavor to provide as much advance notice as possible, and to limit price increases to one per Product per calendar
year, but shall not be bound by this. 
 
Appendix C – PRODUCT
PRICING, as of December 10, 2002 
 

	  Cat. No. 700000
	   	  $600.00

	  Cat. No. 700000FC
	   	  $600.00

	  Cat. No. 98078
	   	  $540.00

	  Cat. No. 98002
	   	  $594.00

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]